ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 130 filers reported holding ATEA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $110,410 | -20.0% | 36,200 | -1.9% | 0.00% | – |
| Q2 2023 | $138,006 | -79.8% | 36,900 | -81.9% | 0.00% | – |
| Q1 2023 | $684,070 | -30.4% | 204,200 | 0.0% | 0.00% | – |
| Q4 2022 | $982,202 | +0.7% | 204,200 | +87.2% | 0.00% | – |
| Q4 2021 | $975,000 | -74.5% | 109,095 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $3,825,000 | -72.5% | 109,095 | -83.1% | 0.00% | -66.7% |
| Q2 2021 | $13,884,000 | +1008.1% | 646,362 | +2054.5% | 0.00% | – |
| Q4 2020 | $1,253,000 | – | 30,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 5,462,079 | $16,659,341 | 12.62% |
| TANG CAPITAL MANAGEMENT LLC | 4,076,741 | $12,434,060 | 1.15% |
| Stonepine Capital Management, LLC | 839,514 | $2,560,518 | 1.11% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $7,581,196 | 0.73% |
| CM Management, LLC | 270,000 | $823,500 | 0.66% |
| EcoR1 Capital, LLC | 6,995,861 | $21,337,376 | 0.55% |
| Acuitas Investments, LLC | 171,098 | $615,373 | 0.32% |
| Newtyn Management, LLC | 508,474 | $1,550,846 | 0.30% |
| Diametric Capital, LP | 161,524 | $492,648 | 0.30% |
| Auour Investments LLC | 177,000 | $670,830 | 0.26% |